EIF3FP1

Across TCGA pan-cancer cohorts, EIF3FP1 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of EIF3FP1’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where EIF3FP1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types EIF3FP1 is over-expressed in tumor, although a few such as UCEC show the opposite, repressed pattern.

LUSC, LIHC, and UCEC are the cancer types where EIF3FP1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in EIF3FP1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUSC	All	II,III,IV	+0.178	.007	4	view →
LIHC	All	All	+0.100	<.001	4	view →
UCEC	All	All	−0.145	.025	2	view →
KIRP	All	All	+0.137	.026	2	view →
CHOL	All	All	+0.120	.010	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

EIF3FP1–LUSC

Open the LUSC breakdown →